Non-COVID-19 respiratory viral infection

Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses,...

Full description

Bibliographic Details
Main Authors: Cláudio Nunes-Silva, Ana Teresa Vilares, Valentijn Schweitzer, Susana Castanhinha, António Martins, Maria João Lopes, Tommaso Ascoli-Bartoli, Gabriela Canelas, Holly R. Keir, Flávia Cunha, André Silva-Pinto, Sandra Rebelo, Rui Guimarães Cunha, Margarida Tavares
Format: Article
Language:English
Published: European Respiratory Society 2022-03-01
Series:Breathe
Online Access:http://breathe.ersjournals.com/content/18/1/210151.full
_version_ 1818549039446097920
author Cláudio Nunes-Silva
Ana Teresa Vilares
Valentijn Schweitzer
Susana Castanhinha
António Martins
Maria João Lopes
Tommaso Ascoli-Bartoli
Gabriela Canelas
Holly R. Keir
Flávia Cunha
André Silva-Pinto
Sandra Rebelo
Rui Guimarães Cunha
Margarida Tavares
author_facet Cláudio Nunes-Silva
Ana Teresa Vilares
Valentijn Schweitzer
Susana Castanhinha
António Martins
Maria João Lopes
Tommaso Ascoli-Bartoli
Gabriela Canelas
Holly R. Keir
Flávia Cunha
André Silva-Pinto
Sandra Rebelo
Rui Guimarães Cunha
Margarida Tavares
author_sort Cláudio Nunes-Silva
collection DOAJ
description Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed. Educational aims To summarise the knowledge on the spectrum of disease that respiratory viral infections can cause and recognise how often they overlap. To learn the most common causes of respiratory viral infections and acknowledge other less frequent agents that may target certain key populations (e.g. immunocompromised patients). To improve awareness of the recent advances in diagnostic methods, including molecular assays and helpful features in imaging techniques. To identify supportive care strategies pivotal in the management of severe respiratory viral infections.
first_indexed 2024-12-12T08:28:16Z
format Article
id doaj.art-13f358baaec245e1bdfb2332b11e1092
institution Directory Open Access Journal
issn 1810-6838
2073-4735
language English
last_indexed 2024-12-12T08:28:16Z
publishDate 2022-03-01
publisher European Respiratory Society
record_format Article
series Breathe
spelling doaj.art-13f358baaec245e1bdfb2332b11e10922022-12-22T00:31:11ZengEuropean Respiratory SocietyBreathe1810-68382073-47352022-03-0118110.1183/20734735.0151-20210151-2021Non-COVID-19 respiratory viral infectionCláudio Nunes-Silva0Ana Teresa Vilares1Valentijn Schweitzer2Susana Castanhinha3António Martins4Maria João Lopes5Tommaso Ascoli-Bartoli6Gabriela Canelas7Holly R. Keir8Flávia Cunha9André Silva-Pinto10Sandra Rebelo11Rui Guimarães Cunha12Margarida Tavares13 Dept of Infectious Diseases, Centro Hospitalar Universitário de São João, Porto, Portugal Medical School, University of Porto, Porto, Portugal Dept of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands Paediatric Pulmonology Unit, Dept of Paediatrics, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal Dept of Infectious Diseases, Centro Hospitalar Universitário de São João, Porto, Portugal Dept of Infectious Diseases, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal Lazzaro Spallanzani, National Institute for Infectious Diseases – IRCCS, Rome, Italy Dept of Infectious Diseases, Centro Hospitalar Universitário de São João, Porto, Portugal Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK Dept of Infectious Diseases, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal Medical School, University of Porto, Porto, Portugal Medical School, University of Porto, Porto, Portugal Medical School, University of Porto, Porto, Portugal Dept of Infectious Diseases, Centro Hospitalar Universitário de São João, Porto, Portugal Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed. Educational aims To summarise the knowledge on the spectrum of disease that respiratory viral infections can cause and recognise how often they overlap. To learn the most common causes of respiratory viral infections and acknowledge other less frequent agents that may target certain key populations (e.g. immunocompromised patients). To improve awareness of the recent advances in diagnostic methods, including molecular assays and helpful features in imaging techniques. To identify supportive care strategies pivotal in the management of severe respiratory viral infections.http://breathe.ersjournals.com/content/18/1/210151.full
spellingShingle Cláudio Nunes-Silva
Ana Teresa Vilares
Valentijn Schweitzer
Susana Castanhinha
António Martins
Maria João Lopes
Tommaso Ascoli-Bartoli
Gabriela Canelas
Holly R. Keir
Flávia Cunha
André Silva-Pinto
Sandra Rebelo
Rui Guimarães Cunha
Margarida Tavares
Non-COVID-19 respiratory viral infection
Breathe
title Non-COVID-19 respiratory viral infection
title_full Non-COVID-19 respiratory viral infection
title_fullStr Non-COVID-19 respiratory viral infection
title_full_unstemmed Non-COVID-19 respiratory viral infection
title_short Non-COVID-19 respiratory viral infection
title_sort non covid 19 respiratory viral infection
url http://breathe.ersjournals.com/content/18/1/210151.full
work_keys_str_mv AT claudionunessilva noncovid19respiratoryviralinfection
AT anateresavilares noncovid19respiratoryviralinfection
AT valentijnschweitzer noncovid19respiratoryviralinfection
AT susanacastanhinha noncovid19respiratoryviralinfection
AT antoniomartins noncovid19respiratoryviralinfection
AT mariajoaolopes noncovid19respiratoryviralinfection
AT tommasoascolibartoli noncovid19respiratoryviralinfection
AT gabrielacanelas noncovid19respiratoryviralinfection
AT hollyrkeir noncovid19respiratoryviralinfection
AT flaviacunha noncovid19respiratoryviralinfection
AT andresilvapinto noncovid19respiratoryviralinfection
AT sandrarebelo noncovid19respiratoryviralinfection
AT ruiguimaraescunha noncovid19respiratoryviralinfection
AT margaridatavares noncovid19respiratoryviralinfection